ClinVar Genomic variation as it relates to human health
NM_024921.4(POF1B):c.986G>A (p.Arg329Gln)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Likely pathogenic(1); Uncertain significance(4); Benign(1)
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_024921.4(POF1B):c.986G>A (p.Arg329Gln)
Variation ID: 10794 Accession: VCV000010794.44
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: Xq21.1 X: 85308188 (GRCh38) [ NCBI UCSC ] X: 84563194 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline May 13, 2017 Apr 15, 2024 Apr 4, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_024921.4:c.986G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_079197.3:p.Arg329Gln missense NM_001307940.2:c.986G>A NP_001294869.1:p.Arg329Gln missense NC_000023.11:g.85308188C>T NC_000023.10:g.84563194C>T NG_016358.1:g.76555G>A Q8WVV4:p.Arg329Gln - Protein change
- R329Q
- Other names
- -
- Canonical SPDI
- NC_000023.11:85308187:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00291 (T)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
1000 Genomes Project 30x 0.00271
The Genome Aggregation Database (gnomAD), exomes 0.00271
Exome Aggregation Consortium (ExAC) 0.00272
1000 Genomes Project 0.00291
The Genome Aggregation Database (gnomAD) 0.00354
Trans-Omics for Precision Medicine (TOPMed) 0.00458
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
POF1B | - | - |
GRCh38 GRCh37 |
82 | 246 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Conflicting interpretations of pathogenicity (6) |
criteria provided, conflicting classifications
|
Apr 4, 2024 | RCV000011541.24 | |
Uncertain significance (1) |
criteria provided, single submitter
|
Jan 1, 2017 | RCV000626964.4 | |
Benign (1) |
criteria provided, single submitter
|
Jun 15, 2018 | RCV000953408.4 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Benign
(Jun 15, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001099981.1
First in ClinVar: Dec 17, 2019 Last updated: Dec 17, 2019 |
|
|
Uncertain significance
(Mar 19, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Premature ovarian failure 2B
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV003809129.2
First in ClinVar: Mar 04, 2023 Last updated: Feb 04, 2024 |
|
|
Uncertain significance
(Jan 01, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Premature ovarian insufficiency
Premature ovarian insufficiency
Affected status: yes
Allele origin:
unknown
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Accession: SCV000747667.1
First in ClinVar: May 12, 2018 Last updated: May 12, 2018 |
|
|
Likely pathogenic
(Mar 26, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Premature ovarian failure 2B
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV000915304.1
First in ClinVar: May 27, 2019 Last updated: May 27, 2019 |
Comment:
Lacombe et al. (2006) identified the POF1B c.986G>A (p.Arg329Gln) variant in a homozygous state in five sisters with POF from a consanguineous Lebanese family. The … (more)
Lacombe et al. (2006) identified the POF1B c.986G>A (p.Arg329Gln) variant in a homozygous state in five sisters with POF from a consanguineous Lebanese family. The variant was also identified in a heterozygous state in the unaffected mother and an unaffected sister. The p.Arg329Gln variant has also been reported in two additional patients with POF, including in a heterozygous state in one patient with a second unidentified variant and in one patient with the p.Arg329Gln variant on one allele and a balanced translocation on the other (Bione et al. 2004; Ledig et al. 2015). The p.Arg329Gln variant was found in a heterozygous state in a total of seven of 992 controls from the above studies, and is reported at a frequency of 0.007634 in the admixed American population of the 1000 Genomes Project. Lacombe et al. (2006) found that in vitro binding to non-muscle actin filaments was diminished four-fold in the p.Arg329Gln variant protein compared to the wild type, and Padovano et al. (2011) demonstrated that cells expressing the p.Arg329Gln variant have mislocalized and misassembled tight junctions, were dysmorphic with altered monolayer organization, and showed defects in ciliogenesis and cystogenesis. Based on the evidence, the p.Arg329Gln variant is classified as as a variant of unknown significance but suspicious for pathogenicity for premature ovarian failure 2B. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. (less)
|
|
Uncertain significance
(Jan 01, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
Premature ovarian failure 2B
Affected status: yes
Allele origin:
unknown
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Accession: SCV001367992.2
First in ClinVar: Jul 04, 2020 Last updated: Dec 12, 2020 |
Comment:
This variant was classified as: Uncertain significance.
|
|
Uncertain significance
(Apr 04, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Premature ovarian failure 2B
Affected status: unknown
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV004810151.1
First in ClinVar: Apr 15, 2024 Last updated: Apr 15, 2024 |
|
|
Pathogenic
(Jul 01, 2006)
|
no assertion criteria provided
Method: literature only
|
PREMATURE OVARIAN FAILURE 2B (1 family)
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000031773.5
First in ClinVar: Apr 04, 2013 Last updated: Mar 14, 2021 |
Comment on evidence:
In 5 affected sisters from a consanguineous Lebanese family in which premature ovarian failure mapped to the Xq21.1-q21.33 region (POF2B; 300604), Lacombe et al. (2006) … (more)
In 5 affected sisters from a consanguineous Lebanese family in which premature ovarian failure mapped to the Xq21.1-q21.33 region (POF2B; 300604), Lacombe et al. (2006) identified homozygosity for a 1132G-A transition in exon 10 of the POF1B gene that resulted in an arg329-to-gln (R329Q) substitution. The R329Q variant altered the arginine within an amino acid triplet, serine-leucine-arginine, that is part of a protein kinase C (PKC; see 176960) phosphorylation recognition site. Lacombe et al. (2006) demonstrated that the capacity of R329Q mutant POF1B protein to bind nonmuscle actin filaments was diminished 4-fold compared with the wildtype protein, suggesting a function of POF1B in germ cell division. (less)
|
|
Likely pathogenic
(Feb 09, 2021)
|
no assertion criteria provided
Method: research
|
Premature ovarian failure 2B
Affected status: yes
Allele origin:
unknown
|
Reproductive Development, Murdoch Childrens Research Institute
Accession: SCV001810164.1
First in ClinVar: Mar 01, 2022 Last updated: Mar 01, 2022 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Premature ovarian failure caused by a heterozygous missense mutation in POF1B and a reciprocal translocation 46,X,t(X;3)(q21.1;q21.3). | Ledig S | Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation | 2015 | PMID: 25676666 |
The POF1B candidate gene for premature ovarian failure regulates epithelial polarity. | Padovano V | Journal of cell science | 2011 | PMID: 21940798 |
Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure. | Lacombe A | American journal of human genetics | 2006 | PMID: 16773570 |
Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B. | Bione S | Human reproduction (Oxford, England) | 2004 | PMID: 15459172 |
Text-mined citations for rs75398746 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.